Pharma Journalist 8887 posts 0 comments

Aptose Biosciences Inc., a clinical-stage precision oncology company developing tuspetinib, a highly differentiated oral kinase inhibitor for the treatment of patients with acute…
Read More...

Eli Lilly and Company announced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding…
Read More...

Astellas Pharma Inc. announced that the European Commission has granted Marketing Authorization for PADCEVTM (enfortumab vedotin, an antibody-drug conjugate ) in combination with…
Read More...

Pfizer Inc. introduced PfizerForAll , a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S.…
Read More...

Roche announced that the European Commission has approved PiaSky (crovalimab), a novel recycling monoclonal antibody that inhibits the complement protein C5, for adults and adolescents…
Read More...

UCB, a global biopharmaceutical company, announced a strategic divestment deal in China, underscoring its strategic shift towards innovation and partnership in one of the world’s…
Read More...

BeiGene, Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BGB-16673, an orally available investigational Bruton’s tyrosine kinase…
Read More...

As BioNTech, Moderna, and Merck have recently released positive phase II clinical results for personalized cancer vaccines, the whole industry is now racing to develop affordable and…
Read More...

The race for clinical approval of TGF-β therapies is heating up, fueled by significant investments like Corbus Pharmaceuticals' recent $98.5 million and Biacara Therapeutics' $165…
Read More...

ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable or metastatic hormone receptor positive…
Read More...